MeSH tree: C19.391.630
Two in five women with ovarian cancer are diagnosed only after an emergency hospital admission, when they are three times less likely to have early-stage and potentially curable disease, finds a data analysis published in ...
Jul 7, 2026
0
3
Polycystic ovary syndrome (PCOS) has been renamed polyendocrine metabolic ovarian syndrome (PMOS). Professor Helena Teede led this name change after 14 years of research and global collaboration. But why was it needed?
Jun 23, 2026
0
4
Researchers at the University of Colorado Anschutz have published a proof-of-concept study in Fertility and Sterility demonstrating that injectable semaglutide may offer meaningful reproductive benefits for women with polyendocrine ...
Jun 10, 2026
0
11
A disease's name can have a significant influence on its diagnosis and treatment—or lack thereof. Polycystic ovary syndrome, or PCOS, is a condition that affects millions of people worldwide. For decades, doctors thought ...
Jun 1, 2026
0
4
An estimated 1 in 8 women live with polycystic ovarian syndrome, commonly referred to as PCOS. However, the name is a bit of a misnomer; it suggests that the condition affects only the ovaries. In actuality, the condition ...
May 29, 2026
0
7
Earlier this month, endocrinology specialists at the European Congress of Endocrinology announced that Polycystic Ovary Syndrome (PCOS) is being renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) to better reflect the ...
May 26, 2026
0
4
"Hopeful," "excited" and "helpful" for the future of women's health—these are just some of the words expressed by the team that worked together for more than a decade to change the name polycystic ovary syndrome (PCOS) to ...
May 18, 2026
0
16
For more than two decades, I have studied a condition that shapes the lives of about 10–13% of women. This condition causes complex, wide-ranging symptoms such as irregular periods, excessive hair growth, weight gain, acne ...
May 18, 2026
0
4
Polycystic Ovary Syndrome, which has just been renamed Polyendocrine Ovarian Syndrome (PMOS), is the most common hormonal and metabolic disorder affecting women of reproductive age, impacting up to 13% of this population ...
May 18, 2026
0
8
When Mayo Clinic researchers sequenced the genomes of 484 seemingly healthy adults, they found that about 13% carried a serious, previously unrecognized genetic risk—conditions those patients did not know about and that standard ...
May 14, 2026
0
4
